FHIR © HL7.org | Server Home | FHIR Server FHIR Server 3.8.2 | FHIR Version n/a User: [n/a]

424204000: Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2641604019 Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core

2645710015 Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core

3558221000005110 ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml	Is a	Product containing ranibizumab (medicinal product)	false	Inferred relationship	Some
ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Ranibizumab (substance)	false	Inferred relationship	Some
ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml	Has manufactured dose form	injektionsvæske	false	Inferred relationship	Some
ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml	Has manufactured dose form	Ocular dose form (dose form)	false	Inferred relationship	Some
ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Angiogenesis inhibitor	false	Inferred relationship	Some
ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml	Is a	TEMPORARY parent for CDs that are not updated	false	Inferred relationship	Some

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
2641604019	Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial (product)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2645710015	Ranibizumab 10mg/mL solution for intravitreal injection 0.05mL vial	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
3558221000005110	ranibizumab 10 mg/ml opløsning til intravitreal injektionsvæske, hætteglas a 0,05 ml	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)